Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Belzutifan	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Belzutifan Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Berzosertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Berzosertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Binimetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Binimetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Bozitinib	MET Inhibitor	Solid Tumour
Molecule Bozitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Brigatinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Brigatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Brivanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Brivanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Cabozantinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Cabozantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Camonsertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Camonsertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Capmatinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Capmatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
CC-94676	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule CC-94676 Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Cediranib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Cediranib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Ceralasertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Ceralasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)

Belzutifan Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Berzosertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Binimetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Bozitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Brigatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Brivanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Cabozantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Camonsertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Capmatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
CC-94676 Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Cediranib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Ceralasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)

‹ 1 2 3 4 5 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Belzutifan

Berzosertib

Binimetinib

Bozitinib

Brigatinib

Brivanib

Cabozantinib

Camonsertib

Capmatinib

CC-94676

Cediranib

Ceralasertib

Belzutifan

Berzosertib

Binimetinib

Bozitinib

Brigatinib

Brivanib

Cabozantinib

Camonsertib

Capmatinib

CC-94676

Cediranib

Ceralasertib